EICHOR
● Not Yet Recruiting
Qatar Cardiometabolic Cohort
Condition: Cardiometabolic Diseases · Sponsor: Weill Cornell Medical College in Qatar
About this study
Our objective is to create a cardiometabolic cohort that could be representative of the local population, consisting of Qataris and long-term residents, in order to identify the prevalence, risk factors, and clinical characteristics of cardiometabolic disorders, as well as the incidence of atherosclerotic cardiovascular disease events.
This description comes directly from the study's public registry record.
Talk to the study team
Charbel Abi khalil, MD,PhD · +974 4492 8484 · cha2022@qatar-med.cornell.edu
Always discuss trial participation with your own doctor first.
Locations (1)
| Hamad Medical Corporation | Doha, Qatar | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07675928